CRISPR/Cas9 advances engineering of microbial cell factories

被引:148
|
作者
Jakociunas, Tadas [1 ]
Jensen, Michael K. [1 ]
Keasling, Jay D. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark
[2] Joint BioEnergy Inst, Emeryville, CA USA
[3] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA
[5] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA
关键词
Genome editing; Metabolic engineering; CRISPR/Cas9; Recombineering; Yeast; Bacteria; DOUBLE-STRAND BREAKS; HETEROLOGOUS GENE-EXPRESSION; ESCHERICHIA-COLI GENOME; SPENT SULFITE LIQUOR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; HIGH-THROUGHPUT; IN-VIVO; CHROMOSOMAL INTEGRATION; PLASMID CONSTRUCTION;
D O I
10.1016/j.ymben.2015.12.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited. As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria. Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9 genome engineering and regulation in the context of metabolic engineering. (C) 2015 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:44 / 59
页数:16
相关论文
共 50 条
  • [31] Engineering Citrobacter freundii using CRISPR/Cas9 system
    Alfaro, Trinidad
    Elmore, Joshua R.
    Stromberg, Zachary R.
    Hutchison, Janine R.
    Hess, Becky M.
    JOURNAL OF MICROBIOLOGICAL METHODS, 2022, 200
  • [32] CRISPR–Cas9 System for Genome Engineering of Photosynthetic Microalgae
    Vikas Kumar Patel
    Niraja Soni
    Venkatesh Prasad
    Ajit Sapre
    Santanu Dasgupta
    Bhaskar Bhadra
    Molecular Biotechnology, 2019, 61 : 541 - 561
  • [33] Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
    Sharma, Aditya Kumar
    Giri, Anil K.
    FRONTIERS IN GENETICS, 2024, 15
  • [34] The CRISPR/CAS9 world
    Perini, Giovanni
    MOLECULAR CYTOGENETICS, 2017, 10
  • [35] What is CRISPR/Cas9?
    Redman, Melody
    King, Andrew
    Watson, Caroline
    King, David
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2016, 101 (04): : 213 - 215
  • [36] Highly parallel genome variant engineering with CRISPR–Cas9
    Meru J. Sadhu
    Joshua S. Bloom
    Laura Day
    Jake J. Siegel
    Sriram Kosuri
    Leonid Kruglyak
    Nature Genetics, 2018, 50 : 510 - 514
  • [37] Engineering the mouse genome using CRISPR/Cas9 technology
    Mianne, Joffrey
    Caulder, Adam
    Codner, Gemma
    King, Ruairidh
    Fell, Rachel
    Maritati, Marina
    Allan, Alasdair
    Jarrold, James
    Fray, Martin
    Gardiner, Wendy
    Wells, Sara
    Teboul, Lydia
    TRANSGENIC RESEARCH, 2016, 25 (02) : 251 - 251
  • [38] CRISPR/CAS9 Technologies
    Williams, Bart O.
    Warman, Matthew L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 883 - 888
  • [39] Surveying the Delivery Methods of CRISPR/Cas9 for ex vivo Mammalian Cell Engineering
    Kelton, William J.
    Pesch, Theresa
    Matile, Stefan
    Reddy, Sai T.
    CHIMIA, 2016, 70 (06) : 439 - 442
  • [40] Genetic engineering using CRISPR/Cas9 as a strategy for the treatment of Sickle Cell Anemia
    Danda Vasconcelos Santos, M.
    Nascimento Ferreira, I.
    Silva Dos Santos, F.
    Silva Souza, K.
    Freire Da Silva, M. R.
    Almeida Candido, M.
    Motteran, F.
    Alexandre De Araujo, L. C.
    Melo De Oliveira, M. B.
    CLINICA CHIMICA ACTA, 2024, 558